Hotline: 1800 102 2007
X
Search Business Opportunities
Jul, 12 2018

Pfizer separates consumer health unit in business rejig

Starting 2019, Pfizer’s new units would be Innovative Medicines, Established Medicines and Consumer Healthcare.

Pfizer Inc announced plans on Wednesday to reorganize into three units, separating its consumer healthcare business that the U.S. drugmaker has been trying to sell since last year.

The company said it is still looking for options for the lower-margin, non-core consumer healthcare business that makes products ranging from painkiller Advil to lip balms and is worth about $15 billion.

“Given the lack of urgency, management is being rational about its divestiture,” BMO Capital Markets analyst Alex Arfaei said, adding the new structure will help Pfizer maintain its options for the business.

The news comes a day after Pfizer deferred drug price increases for no more than six months, following criticism from U.S. President Donald Trump.

Starting 2019, Pfizer’s new units would be Innovative Medicines, Established Medicines and Consumer Healthcare.

The company is currently split into two units - Innovative Medicines, which includes the consumer business, and Essential Health which houses legacy drugs such as Viagra.

“This design gives us a sharper focus on diverse patients in diverse markets,” Albert Bourla, chief operating officer, said.

The innovative medicines business will include biosimilars and a new hospital business unit, and together with the consumer healthcare business, will account for about three-quarters of the company’s revenue. Pfizer’s 2017 annual revenue was $52.55 billion.

The established medicines unit would now include a majority of the company’s brands such as soon-to-be off-patent neurological disease treatment Lyrica as well as some generic drugs.

The restructuring will allow the company to evaluate its businesses better and could result in selling or spinning off its off-patent drugs, Wall Street analysts said.

While the company expects the business to generate sustainable moderate revenue growth after Lyrica goes generic, Credit Suisse analyst Vamil Divan said the reorganization would allow the established medicines unit to have more autonomy.

 “We believe the potential for Pfizer to ultimately sell or spin the business likely remains on the table over time,” Divan said.

Pfizer shares were trading marginally down at $37.27 in early trading.

Comment
image
Related opportunities
  • Chocolate Stores
    About Us: It was established in 2007 in India and originates..
    Locations looking for expansion Delhi
    Establishment year 2007
    Franchising Launch Date 2008
    Investment size Rs. 30lac - 50lac
    Space required 100
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • Fine Dine Restaurants
    About Us: Karim’s, a division of Karim’s Hotels Private Limited, is..
    Locations looking for expansion Delhi
    Establishment year 1950
    Franchising Launch Date 2018
    Investment size Rs. 50lac - 1 Cr.
    Space required 250
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • Juices / Smoothies / Dairy parlors
    About Us: At Lassi Corner, we strive to help people transform..
    Locations looking for expansion Karnataka
    Establishment year 2016
    Franchising Launch Date 2017
    Investment size Rs. 5lac - 10lac
    Space required 125
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Bangalore Karnataka
  • Snacks / Namkeen shops
    About Us: Shyam sunder Foods established in 1969 by Late Shri..
    Locations looking for expansion Gujarat
    Establishment year 2018
    Franchising Launch Date 2019
    Investment size Rs. 5lac - 10lac
    Space required 150
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Ahmedabad Gujarat
Insta-Subscribe to
Entrepreneur
Magazine
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities